http://cat.sagepub.com/content/22/1/42.abstract?
- Golnaz Yadollahikhales, MD1
- Afshin Borhani-Haghighi, MD1,2⇑
- Mohammad Torabi-Nami, MD, PhD3
- Randall Edgell, MD4
- Salvador Cruz-Flores, MD, MPH5
- 1Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran
- 2Neurology Department, Namazi hospital, Shiraz, Fars, Iran
- 3Department of Neuroscience, School of Advanced Medical Science and Technologies, Shiraz University of Medical sciences, Shiraz, Fars, Iran
- 4Departments of Neurology and Psychiatry, Saint Louis University, Saint Louis, MO, USA
- 5Department of Neurology, Texas Tech University, El Paso, TX, USA
- Afshin Borhani-Haghighi, Clinical Neurology Research Center, Namazi hospital, Zand St. 71937, Shiraz, Fars, Iran. Email: aborhani@sums.ac.ir
Abstract
There is an urgent need for additional
therapeutic options for acute ischemic stroke considering the major
pitfalls of the
options available. Herein, we briefly review the
role of cerebral blood flow, collaterals, vasoreactivity, and
reperfusion
injury in acute ischemic stroke. Then, we reviewed
pharmacological and interventional measures such as volume expansion and
induced hypertension, intra-aortic balloon
counterpulsation, partial aortic occlusion, extracranial–intracranial
carotid bypass
surgery, sphenopalatine ganglion stimulation, and
transcranial laser therapy with regard to their effects on flow
augmentation
and neuroprotection.
-
January 2016 vol. 22 no. 1 42-51CLIN APPL THROMB HEMOST
- » AbstractFree
- Full Text (PDF)
No comments:
Post a Comment